Indian equities were trading little changed in the late morning deals on Thursday led by increased buying by funds and retail investors mainly in the healthcare and FMCG sector stocks amid weak cues from other Asian peers.
At 11:17 hours, the 30-share barometer index of Bombay Stock Exchange, Sensex was at 27939.07, up by 7.43 points or 0.03 per cent while the NSE Nifty was at 8481.35, down by 13.8 points or 0.16 per cent.
The market sentiments were also dampened on fears that a further depreciation of the rupee may delay an interest rate cut by the Reserve Bank of India (RBI) which meets next on the 29th of September.
The top gainers of the BSE Sensex pack were Lupin Ltd. (Rs. 1927.35,+7.35%), Sun Pharmaceutical Industries Ltd. (Rs. 963.35,+3.89%), ITC Ltd. (Rs. 324.75,+2.56%), Hindustan Unilever Ltd. (Rs. 894.50,+2.15%), Dr. Reddy's Laboratories Ltd. (Rs. 4294.75,+1.49%), among others.
Major show spoilers were Vedanta Ltd. (Rs. 99.45,-3.07%), GAIL (India) Ltd. (Rs. 321.60,-2.62%), Infosys Ltd. (Rs. 1145.50,-2.51%), Tata Steel Ltd. (Rs. 243.80,-2.44%), Oil And Natural Gas Corporation Ltd. (Rs. 255.10,-2.22%), among others.
The market breadth, indicating the overall health of the market, was weak. On BSE, out of the total 2373 shares traded, 973 advanced while 1308 shares declined and 92 remained unchanged.
On the global front, Asian markets were trading deep in the red as minutes from the Fed"s latest meet, highlighted concerns over weak inflation amidst anaemic global demand while investors remained nervous over China as the country"s slowdown continued to fuel a rout in emerging market assets and commodities, dimming the lure for risky assets.